Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

104 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regulation of energy metabolism in pancreatic islets by glucose and tolbutamide.
Panten U, Zünkler BJ, Scheit S, Kirchhoff K, Lenzen S. Panten U, et al. Diabetologia. 1986 Sep;29(9):648-54. doi: 10.1007/BF00869265. Diabetologia. 1986. PMID: 3539682
Defective regulation of glucokinase in rat pancreatic islet cell tumours.
Lenzen S, Tiedge M, Flatt PR, Bailey CJ, Panten U. Lenzen S, et al. Among authors: panten u. Acta Endocrinol (Copenh). 1987 Aug;115(4):514-20. doi: 10.1530/acta.0.1150514. Acta Endocrinol (Copenh). 1987. PMID: 2820174
Glucose both inhibits and stimulates insulin secretion from isolated pancreatic islets exposed to maximally effective concentrations of sulfonylureas.
Panten U, Schwanstecher M, Wallasch A, Lenzen S. Panten U, et al. Naunyn Schmiedebergs Arch Pharmacol. 1988 Oct;338(4):459-62. doi: 10.1007/BF00172128. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3149719
Cytosolic ADP enhances the sensitivity to tolbutamide of ATP-dependent K+ channels from pancreatic B-cells.
Zünkler BJ, Lins S, Ohno-Shosaku T, Trube G, Panten U. Zünkler BJ, et al. Among authors: panten u. FEBS Lett. 1988 Nov 7;239(2):241-4. doi: 10.1016/0014-5793(88)80925-6. FEBS Lett. 1988. PMID: 3053250
Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
Schwanstecher M, Mnner K, Panten U. Schwanstecher M, et al. Among authors: panten u. Pharmacology. 1994 Aug;49(2):105-11. doi: 10.1159/000139222. Pharmacology. 1994. PMID: 7972319
Alloxan: history and mechanism of action.
Lenzen S, Panten U. Lenzen S, et al. Among authors: panten u. Diabetologia. 1988 Jun;31(6):337-42. doi: 10.1007/BF02341500. Diabetologia. 1988. PMID: 3046975 Review. No abstract available.
Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
Panten U, Burgfeld J, Goerke F, Rennicke M, Schwanstecher M, Wallasch A, Zünkler BJ, Lenzen S. Panten U, et al. Biochem Pharmacol. 1989 Apr 15;38(8):1217-29. doi: 10.1016/0006-2952(89)90327-4. Biochem Pharmacol. 1989. PMID: 2650685
Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells.
Zünkler BJ, Lenzen S, Männer K, Panten U, Trube G. Zünkler BJ, et al. Among authors: panten u. Naunyn Schmiedebergs Arch Pharmacol. 1988 Feb;337(2):225-30. doi: 10.1007/BF00169252. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2452991
Alloxan and ninhydrin inhibition of hexokinase from pancreatic islets and tumoural insulin-secreting cells.
Lenzen S, Freytag S, Panten U, Flatt PR, Bailey CJ. Lenzen S, et al. Among authors: panten u. Pharmacol Toxicol. 1990 Mar;66(3):157-62. doi: 10.1111/j.1600-0773.1990.tb00725.x. Pharmacol Toxicol. 1990. PMID: 2185463
Tolbutamide-sensitivity of the adenosine 5'-triphosphate-dependent K+ channel in mouse pancreatic B-cells.
Panten U, Heipel C, Rosenberger F, Scheffer K, Zünkler BJ, Schwanstecher C. Panten U, et al. Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):566-74. doi: 10.1007/BF00169047. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2090953
104 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback